"Dose or Strength to be Studied" in ICH M13A [Regulatives / Guidelines]

posted by Darborn – Taiwan, 2024-10-08 02:58 (273 d 11:29 ago) – Posting: # 24223
Views: 2,117

Thanks BEQool for the reply,

I totally agree with your point that a separate paragraph will be needed if it truly means that all high-risk products should be conducting those studies. However, this still needs to be clarified by the authorities. :yes:

Best regard

Complete thread:

UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,697 registered users;
87 visitors (0 registered, 87 guests [including 17 identified bots]).
Forum time: 14:27 CEST (Europe/Vienna)

Anyone who conducts an argument by appealing to authority
is not using his intelligence;
he is just using his memory.    Leonardo da Vinci

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5